The European Food Safety Authority’s (EFSA) has confirmed the safety and efficacy of dsm-firmenich Animal Nutrition and Health’s vitamin D3 metabolite, Hy-D®, for aquatic and all other animal species, marking a pivotal regulatory step for the company.
dsm-firmenich Animal Nutrition & Health has reached a pivotal regulatory step following the European Food Safety Authority’s (EFSA) published scientific opinion confirming the safety and efficacy of 25-hydroxycholecalciferol (25-OH-D₃) exclusively produced with Saccharomyces cerevisiae CBS 146008 for salmonids, other fish species, and all other animal species. The confirmation extends the recognized safety and efficacy of Hy-D® beyond poultry, swine, and ruminants to the entire spectrum of terrestrial and aquatic animals.
Hy-D®, an innovative vitamin D3 metabolite, supports optimal levels of 25-OH-D₃, providing all-round benefits in animal health and performance, dsm-firmenich highlights.
Emrah Mazi, Head of Special Nutrients at dsm-firmenich Animal Nutrition & Health said, “This opinion from ESFA marks a key milestone for Hy-D®, demonstrating its global relevance and potential as a reliable source of vitamin D across all animal species. We are excited about what this means for the future of Hy-D® in helping customers around the world advance animal health and performance with confidence.”
The company explains that Hy-D® offers significant benefits for animals, including health and welfare, performance and productivity, and overall food quality. Proper usage of Hy-D® can positively impact animal wellbeing and productivity.
Final authorization from the European Commission remains pending and is expected to take several months. Subject to approval, Hy-D® could be available for use in the EU for aquaculture and all other animal species by early 2026.
This milestone advances the company’s mission to deliver safe, effective, and sustainable nutritional solutions, bringing Hy-D® one step closer to its full species-wide potential, the announcement concludes.
